National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 66665 [2016-23314]

Download as PDF 66665 Federal Register / Vol. 81, No. 188 / Wednesday, September 28, 2016 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Responses per respondent Total responses Average burden per response (in hours) Total burden hours New review participants ....................................................... Updating review participants information ............................. 250 5,000 1 1 250 5,000 .166 .333 42 1,665 Total .............................................................................. 5,250 ........................ 5,250 ........................ 1,707 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2016–23306 Filed 9–27–16; 8:45 am] Notice of Listing of Members of the National Institutes of Health’s Senior Executive Service 2016 Performance Review Board (PRB) The National Institutes of Health (NIH) announces the persons who will serve on the National Institutes of Health’s Senior Executive Service 2016 Performance Review Board. FOR FURTHER INFORMATION CONTACT: For further information about the NIH Performance Review Board, contact the Office of Human Resources Division of Senior and Scientific Executive Management, National Institutes of Health, Building 2, Room 5E18, Bethesda, Maryland 20892, telephone 301–402–7999 (not a toll-free number). SUPPLEMENTARY INFORMATION: This action is being taken in accordance with Title 5, U.S.C., Section 4314(c)(4), which requires that members of performance review boards be appointed in a manner to ensure consistency, stability, and objectivity in performance appraisals and requires that notice of the appointment of an individual to serve as a member be published in the Federal Register. The following persons will serve on the NIH Performance Review Board, mstockstill on DSK3G9T082PROD with NOTICES Jkt 238001 BILLING CODE 4140–01–P National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting National Institutes of Health 18:04 Sep 27, 2016 [FR Doc. 2016–23391 Filed 9–27–16; 8:45 am] National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 Dated: September 22, 2016. Francis S. Collins, Director, National Institutes of Health. DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4165–15–P SUMMARY: which oversees the evaluation of performance appraisals of NIH Senior Executive Service (SES) members: Alfred Johnson, Chair, Joellen Austin, Michelle Bulls, Michael Gottesman, Michael Lauer, Andrea Norris, LaVerne Stringfield, Lawrence Tabak, Timothy Wheeles. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual grant applications conducted by the NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIDDK. Date: October 20, 2016. Open: 8:00 a.m. to 8:30 a.m. PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Agenda: Introductions and Overview. Place: National Institutes of Health, Building 10, 9th Floor, Bunim Room 9S233, 10 Center Drive, Bethesda, MD 20892. Closed: 8:30 a.m. to 4:30 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 10, 9th Floor, Bunim Room 9S233, 10 Center Drive, Bethesda, MD 20892. Contact Person: Michael W. Krause, Ph.D., Scientific Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, Building 5, Room B104, Bethesda, MD 20892–1818, (301) 402–4633, mwkrause@helix.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: September 22, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–23314 Filed 9–27–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 81, Number 188 (Wednesday, September 28, 2016)]
[Notices]
[Page 66665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23314]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Board of Scientific Counselors, NIDDK.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The meeting will be closed to 
the public as indicated below in accordance with the provisions set 
forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, 
discussion, and evaluation of individual grant applications conducted 
by the NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY 
DISEASES, including consideration of personnel qualifications and 
performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors, NIDDK.
    Date: October 20, 2016.
    Open: 8:00 a.m. to 8:30 a.m.
    Agenda: Introductions and Overview.
    Place: National Institutes of Health, Building 10, 9th Floor, 
Bunim Room 9S233, 10 Center Drive, Bethesda, MD 20892.
    Closed: 8:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Building 10, 9th Floor, 
Bunim Room 9S233, 10 Center Drive, Bethesda, MD 20892.
    Contact Person: Michael W. Krause, Ph.D., Scientific Director, 
National Institute of Diabetes and Digestive and Kidney Diseases, 
National Institute of Health, Building 5, Room B104, Bethesda, MD 
20892-1818, (301) 402-4633, mwkrause@helix.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: September 22, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-23314 Filed 9-27-16; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.